Publications by authors named "N Azambuja"
Introduction: The management of refractory obstructive hydrocephalus is a paramount neurosurgical challenge. The endoscopic third ventriculostomy (ETV) has been accepted as the procedure of choice for obstructive hydrocephalus, depending on the presence of certain risk factors, such as intracranial infections, young age, previous shunt failure and distorted anatomy of the ventricular floor, that predispose occlusion or obstruction of the CSF outflow through the stoma.
Case Report: A 20-year-old man with obstructive hydrocephalus due to primary aqueductal stenosis performed several neurosurgical procedures, including two previous ETV, without long term resolution.
Article Synopsis
- A study was conducted on 36 patients with refractory epileptic drop attacks to evaluate the safety and effectiveness of a selective posterior callosotomy, which preserves prefrontal interconnectivity.
- The procedure significantly reduced the frequency of drop attacks from an average of 150 per month to just 0.5, with 83% of patients achieving over 90% reduction in falls.
- Overall patient autonomy improved, caregivers reported positive outcomes, and no negative side effects on speech or mobility were observed, indicating the approach is beneficial for patients with intellectual disabilities.
Objective: To establish preoperatively the localization of the cortical projection of the inferior choroidal point (ICP) and use it as a reliable landmark when approaching the temporal horn through a middle temporal gyrus access. To review relevant anatomical features regarding selective amigdalohippocampectomy (AH) for treatment of mesial temporal lobe epilepsy (MTLE).
Method: The cortical projection of the inferior choroidal point was used in more than 300 surgeries by one authors as a reliable landmark to reach the temporal horn.
Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.
View Article and Find Full Text PDF